ResMed Inc. ResMed Inc.

ResMed Inc.

RMD

Rang in aandelen #709
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Aandeelprijs
$245.89
Marktkapitalisatie
$34.58B
Verandering (1 dag)
0.13%
Verandering (1 jaar)
-8.33%
Land
US
Handel ResMed Inc. (RMD)

Categorie

Healthcare
Omzet van ResMed Inc. (RMD)
Omzet in Jun 2026 TTM: $5.65B
Volgens de laatste financiële rapporten van ResMed Inc. bedraagt de huidige omzet van het bedrijf (TTM) $5.65B. In 2024 behaalde het bedrijf een omzet van $4.69B een stijging ten opzichte van de omzet in het jaar 2023, die $4.22B bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van ResMed Inc. van 2000 tot 2026
Omzet aan het einde van elk jaar
Jaar Omzet Wijzigen
2026 (TTM) $5.65B 9.85%
2025 $5.15B 9.84%
2024 $4.69B 10.95%
2023 $4.22B 18.02%
2022 $3.58B 11.93%
2021 $3.20B 8.11%
2020 $2.96B 13.44%
2019 $2.61B 11.38%
2018 $2.34B 13.23%
2017 $2.07B 12.40%
2016 $1.84B 9.52%
2015 $1.68B 7.97%
2014 $1.55B 2.68%
2013 $1.51B 10.66%
2012 $1.37B 10.08%
2011 $1.24B 13.80%
2010 $1.09B 18.64%
2009 $920.74M 10.22%
2008 $835.40M 16.62%
2007 $716.33M 18.01%
2006 $607.00M 42.65%
2005 $425.51M 25.39%
2004 $339.34M 24.04%
2003 $273.57M 34.05%
2002 $204.08M 31.53%
2001 $155.16M 34.20%
2000 $115.62M 0.00%
Omzet van vergelijkbare bedrijven of concurrenten
Bedrijf Omzet Omzetverschil Land
$46.59B 724.01%
US
$35.48B 527.65%
IE
$25.84B 357.01%
US
$21.00B 271.38%
US
- -
DE